With TOR less is more: a key role for the conserved nutrient sensing TOR pathway in aging

Introduction

TOR belongs to a conserved group of serine/threonine kinases from the phosphatidylinositol kinase-related kinase (PIKK) family. Rapamycin, an immunosuppressive macrolide, that was first discovered as the product of the bacterium Streptomyces hygroscopicus from the Easter Island (Rapa Nui), inhibits the activity of TOR (Heitman et al., 1991). TOR, first identified in yeast and since then in all eukaryotes examined, exists in two distinct complexes with different functions (Martin and Hall, 2005). TOR complex I (TORC1) is rapamycin sensitive and is the central element of the TOR signaling network (Figure 1). It monitors and integrates a diverse set of intra- and extracellular parameters and controls cell size, proliferation and lifespan via a variety of downstream pathways. It is composed of the Serine/Threonine kinase TOR, and its associated proteins Raptor (regulatory associated protein of TOR), mLst8, PRAS40, and, in mammals, Deptor (Guertin and Sabatini, 2005, 2009; Wullschleger et al., 2006). On the other hand, TOR complex 2 (TORC2) is rapamycin-insensitive and controls the activity of Serum and Glucocorticoid-induced kinase (SGK) and contributes to the full activation of Akt (Alessi et al., 2009). It contains TOR, Rictor (rapamycin-insensitive companion of mTOR), Sin1, Proctor/PRR5L, mLst8 and (again, only in mammals) Deptor (Guertin and Sabatini, 2005, 2009; Wullschleger et al., 2006).

The TOR signaling network can be schematized by connecting discrete signaling modules sensing and relaying diverse inputs to a central “signaling core” (Figure1). This core consists of the Serine/Threonine kinase Akt, the Tuberous Sclerosis Complex proteins Tsc1 and Tsc2, the Ras-like small GTPase Rheb and TORC1 itself. In mammals the activity of TORC1 is held in check by three inhibitory elements within this cascade: the Tsc1/Tsc2 complex, PRAS40 and Deptor (Peterson et al., 2009). The biochemical nature of how the signal cascades though the pathway has been exquisitely reviewed and is only summarized here (Guertin and Sabatini, 2009; Shamji et al., 2003; Shaw and Cantley, 2006; Wullschleger et al., 2006). In short, the activation of the TORC1 signaling core occurs by an Akt-driven de-repression mechanism. Once activated by upstream signals, Akt phosphorylates and inhibits the negative regulators Tsc2 and PRAS40, which then activates the GTPase Rheb and releases TORC1 from inhibition.

Despite the evolutionary conservation of individual components of the TOR pathway, some significant differences exist between species. Of note, baker’s yeast (S. cerevisiae) and fission yeast (S. pombe) contain two genes encoding TOR, which are differentially incorporated into the distinct TORC complexes (Loewith et al., 2002). However, S. pombe hosts genes for the Rheb GTPase and the Tsc1/Tsc2 complex, while S. cerevisiae does not. The nematode C. elegans lacks a functional equivalent to the Tsc1/Tsc2 complex, but connects the activity of Akt and TORC1 by Akt dependent transcriptional regulation of Raptor (Jia et al., 2004; Wullschleger et al., 2006). Despite these differences, the TOR signaling network controls a conserved set of physiological processes in multiple species (see below).

TOR plays a conserved role in coupling nutrients to growth

Since its discovery as a regulator of growth in S. cerevisiae, TOR has been shown to be a conserved nutrient sensor across species. This has been reflected in the common loss-of-function phenotypes of TOR in multiple species. In C. elegans, deletion of CeTOR leads to developmental arrest at the L3 larval stage and intestinal atrophy (Long et al., 2002). A similar phenotype was observed for mutants in daf-15, the worm ortholog of the mammalian protein raptor (Jia et al., 2004). In D. melanogaster, larvae lacking TOR show similarities to amino acid-deprived animals, such as developmental arrest, reduced nucleolar size and lipid vesicle aggregation in the larval fat body (Oldham et al., 2000; Zhang et al., 2000). Similar to invertebrates, loss of function of mammalian TOR (mTOR) in mice leads to early embryonic lethality (Hentges et al., 2001; Murakami et al., 2004). The tissue-specific removal of raptor in skeletal muscle induces progressive muscle dystrophy, which is likely due to impaired protein synthesis (Bentzinger et al., 2008). Thus, mutations in TOR show developmental or growth arrest phenotypes in different species, comparable to those observed upon nutrient deprivation, supporting the notion that it has a conserved role in coupling of availability of nutrients to growth in multiple species.

TOR integrates extra- and intracellular signals from nutrients, growth factors and various stresses

In addition to playing a conserved role as a common nutrient sensor, TORC1 acts as a major hub integrating signals emanating from a variety of sources and influencing multiple physiological responses (Figure 1). TORC1 receives signals from growth factors, nutrients, energy status and a range of stressors. This has lead to the view that TOR signaling serves as a ‘growth checkpoint,’ surveying the extra and intracellular milieu for favorable conditions to mediate growth accordingly (Shaw and Cantley, 2006). This ability to balance a multitude of signals is reflected in the number of signaling modules linked to the central signaling core (Figure 1). Multiple inputs are integrated and relayed towards the regulation of a number of downstream pathways. TORC1 activity influences mRNA translation, autophagy, transcription, metabolism and cell survival, proliferation, size and growth, in addition to number of other cellular processes. An accumulating body of data suggests that some of these responses influence organismal lifespan.

To ensure that growth rates match resources, both the quality and quantity of the nutrient status needs to be assessed and integrated. It seems that the eukaryotic cell has solved this problem by utilizing the TOR signaling network as an important checkpoint (Figure 1). Withdrawal of amino acids acts as a powerful inhibitor of TORC1 activity, even in the presence of acute growth factor stimulation (Hara et al., 1998). Essential amino acids like L-tryptophan, L-phenylalanine, L-arginine and especially L-leucine activate TORC1 after being transported into the cell in an L-glutamine-dependent manner (Nicklin et al., 2009). While it remains unclear how amino acid sufficiency is sensed within the cytoplasm of the cell, two small heterodimeric GTPases, RagA/RagC and RagB/RagD have been shown to relay the signal of amino acid sufficiency to TORC1 (Kim et al., 2008; Sancak et al., 2008). TOR also responds to the energy charge within the cell which is influenced by the presence of nutrients like glucose. A drop in the cell’s energy content is reflected in the rise of the AMP/ATP ratio and triggers AMP-dependent activation of AMP dependent kinase (AMPK) (Hardie, 2007). In turn, AMPK reduces the activity of the TOR signaling core by direct phosphorylation on two key proteins: It phosphorylates and stimulates Tsc2 activity, and further reduces TORC1 by inhibitory Raptor phosphorylation (Gwinn et al., 2008). In addition to nitrogen starvation, carbon and phosphate starvation also lead to inhibition of TORC1 in S. cerevisiae (Kuruvilla et al., 2001; Shamji et al., 2000; Urban et al., 2007). Hence, the TOR pathway integrates information on cellular status by sensing both qualitative and quantitative changes in nutrients.

As noted above, unicellular organisms sense and directly respond to the presence or absence of nutrients, such as amino acids and glucose, to control growth. In multicellular organisms, the requirement for coordination of growth in different tissues creates a need for intercellular communication, which is achieved by diffusible growth factors. In order to gauge the appropriateness of these growth signals, multicellular organisms have evolved to integrate various growth factors and direct nutrient inputs. The role of TORC1 as a major hub for integration of control of growth is supported by the observations that its activity is modulated by various growth-signaling pathways. Growth factors like IGF and insulin modulate TORC1 activity through Akt. Wnt signaling has also been demonstrated to regulate TORC1 activity (Inoki and Guan, 2006). Stimulation of the Wnt receptors culminates in the inhibition of glycogen synthase kinase 3 (Gsk3). When active, Gsk3 has been shown to directly phosphorylate and activate Tsc2 when primed by AMPK-dependent phosphorylation (Inoki et al., 2006). Therefore, Wnt mediated inactivation of Gsk3 alleviates Tsc2-driven inhibition of Rheb and results in TORC1 activation. Inputs from various other growth factors, like that from transforming growth factor (TGF) beta (Lamouille and Derynck, 2007), further endorse TORC1’s role in sensing extracellular growth status.

In addition to nutrients and growth factors, appropriate control of cell growth also requires integration of information on environmental stresses. Hence, it is not surprising that multiple stresses also modulate TORC1 activity. TORC1 is rendered less active by high temperature, hydrogen peroxide and high salt stress in S. cerevisiae (Urban et al., 2007). Correspondingly, osmotic stress inactivates TORC1 by modulating mitochondrial function (Desai et al., 2002). TORC1 also responds to hypoxia. Low oxygen levels stabilize HIF1α, allowing the formation of a heterodimer with the aryl hydrocarbon receptor nuclear translocator (ARNT). The HIF1a/ARNT dimer activates the transcription of hypoxic response genes, most notably REDD1 that inhibits TORC1 activity by a TSC2-dependent mechanism (Brugarolas et al., 2004; Reiling and Hafen, 2004). Genotoxic stress has also been shown to inhibit TORC1. Sestrin1 and Sestrin2, both transcriptional targets of the DNA damage sensor p53, activate AMPK, thereby inhibiting TOR pathway activity (Budanov and Karin, 2008). Hence, sensing of inputs from nutrients, growth factors and cellular stress signals, uniquely positions TORC1 to synchronize growth in tune with its environment.

In summary, the TOR signaling network integrates information from a variety of inhibitory and stimulatory environmental signals. Some of the key questions in the field include: 1) how are multiple nutrients, growth factors and stress inputs quantitatively integrated into a single TORC1 activity level, 2) are the physiological responses downstream of TORC1 differentially regulated by TORC1 activity and if yes, how so, and 3) how does TOR mediate changes in survival and lifespan in response to various environmental manipulations, especially nutrients? In the rest of this article we will discuss the emerging evidence for this final question, which has become of growing interest and may also help illuminate the role of TOR in various human diseases.

The TOR signaling network mediates the protective effects of dietary restriction in different species

Aging is the single largest risk factor for disease in developed countries and arguably the single greatest challenge for biomedicine. Dietary restriction (DR) is the most robust environmental method to slow down aging in species as diverse as yeast, worms, fruit flies, rodents (Masoro, 2003) and recently even primates (Colman et al., 2009). DR also slows the progression of most age-related diseases, including some cancers, neurodegeneration and cardiovascular diseases (Masoro, 2003). DR is classically defined as a reduction of particular or total nutrient intake without causing malnutrition. In practice, DR is applied as an overall reduction of the caloric intake (calorie restriction), the restriction of a particular class of nutrients, temporal variations of food intake, or combinations thereof. Due to its robustness and strong conservation across species, identifying the molecular mechanisms that modulate lifespan upon DR holds great promise for providing insight into the mechanisms of aging. Examination of the molecular and genetic foundation of this protective response is moving at a feverish pace in the last few years. This has been made possible largely due to the short lifespan and powerful genetic tools that are available in S. cerevisiae, C. elegans and D. melanogaster. One of the proposed evolutionary mechanisms of DR is that under conditions of nutrient limitation, there is a shift in metabolic investment from reproduction and growth towards somatic maintenance to ensure extended survival (Holliday, 1989). Abundant evidence for TORC1 as a conserved nutrient sensor makes it an attractive candidate to mediate this switch between growth and somatic maintenance to extend lifespan by DR.

In S. cerevisiae, DR due to limitation of glucose has been shown to robustly extend lifespan. Replicative lifespan, measured by the number of replication events from a single mother yeast cell is increased when TOR activity is diminished. Furthermore, lowering glucose levels did not further extend lifespan of a tor1 deletion mutant (Kaeberlein et al., 2005). Hence, the TOR pathway mediates lifespan extension by DR imposed by limiting glucose concentrations in S. cerevisiae. Inhibition of TOR also extends yeast chronological lifespan (CLS), which measures the ability of stationary (in the absence of nutrients) cultures to maintain viability over time (Bonawitz et al., 2007; Powers et al., 2006).

Various components of the TOR signaling network have also been shown to mediate lifespan extension by DR imposed by different methods in C. elegans. Down-regulation of TOR expression by RNAi in C. elegans during adulthood results in lifespan extension (Vellai et al., 2003). This effect is independent of the FOXO ortholog DAF-16 (Vellai et al., 2003), a transcription factor that is required to mediate the lifespan extension caused by reduced insulin-like signaling (ILS) pathway activity (Guarente and Kenyon, 2000). Heterozygous daf-15 mutants, the worm ortholog of the mammalian protein raptor, display an extended lifespan, again lending credence to the hypothesis that partial inhibition of TORC1 activity suffices to extend life span in model organisms (Jia et al., 2004). Genes in the TOR pathway have been implicated in mediating the lifespan extension imposed by reducing bacterial food concentration in the diet of C. elegans (Chen et al., 2009b; Honjoh et al., 2009). In a model distinct from reducing available food, the eat-2 mutation, which causes pharyngeal pumping defects in C. elegans have been proposed to extend lifespan by eliciting a DR-like response (Lakowski and Hekimi, 1998). Additional inhibition of the TOR pathway and its downstream genes in an eat-2 mutant background does not further extend lifespan, suggesting that DR and lowered TORC1 signaling act by overlapping mechanisms (Chen et al., 2009b; Hansen et al., 2008).

In D. melanogaster, restriction of total food yields extended lifespan (Clancy et al., 2002; Mair et al., 2003; Rogina et al., 2002). A number of groups have shown that reducing yeast (the major source of protein in the fly diet) alone is also sufficient to extend lifespan in D. melanogaster (Chippindale et al., 1993; Kapahi et al., 2004; Mair et al., 2005). Overexpression of either Tsc1 or Tsc2, or dominant-negative forms of dTOR extend lifespan in D. melanogaster (Kapahi et al., 2004). Fat and muscle were observed to be the key tissues responsible for the lifespan extension effects of inhibiting TOR signaling in D. melanogaster (Kapahi et al., 2004). Under conditions of DR imposed by restricting dietary yeast, inhibition of the TOR pathway resulted in no further extension of lifespan. These findings support the idea that TOR mediates lifespan extension by DR in flies (Kapahi et al., 2004).

The role of the TOR signaling network in mediating mammalian aging phenotypes is also beginning to emerge. Long-lived Ames dwarf mice harbor mutations in a gene called Prop-1 that disrupts pituitary gland development (Bartke and Brown-Borg, 2004; Brown-Borg, 2009). It has been proposed that these mice show reduced protein synthesis possibly via inhibition of TOR signaling (Sharp and Bartke, 2005). These data support the notion that reduced signaling downstream of TOR extends lifespan in mice. The National Institute on Aging initiated the Interventions Testing Program (ITP) to evaluate drugs that putatively delay aging or prevent multiple forms of late-life disease in laboratory mice in three different laboratories. The administration of the TORC1 inhibitor rapamycin late in life (aged 600 days) was sufficient to cause a lifespan extension at all three sites (p<0.05) in both sexes, although there are sex-specific differences (males 9%, females 13%) (Harrison et al., 2009). A second study also demonstrated that rapamycin treatment, initiated past middle age (22–24 months old) increases lifespan in mice. This study also showed that under these conditions, rapamycin treatment can boost immune function and rejuvenate hematopoietic stem cells (Chen et al., 2009a). The role of TORC1 has also been tested in models of cellular senescence in culture. Notably, the effects of Doxorubicin (DOX), a DNA damaging agent mediating cellular senescence in normal human cells, were rescued by treatment with rapamycin (Demidenko and Blagosklonny, 2008). Together these data give promise to the notion that reduced TORC1 signaling may extend lifespan even in mammals.

These data emphasize the importance of TORC1 activity in mediating lifespan extension in multiple species and under different methods of nutrient manipulation. TORC2 plays a minor role in modulating lifespan. A study using C. elegans demonstrated that a mutant in Rictor shows lifespan shortening on feeding standard bacteria, but extends lifespan when fed certain types of nutrient-rich bacteria (Soukas et al., 2009). The discovery that the TOR signaling network mediates lifespan extension caused by nutrient modulation in invertebrate and vertebrate species provides a framework to examine the genetic and molecular basis of how DR extends lifespan. Strong inhibition of TORC1 early in life (embryogenesis or larval stages) drastically slows or even stops development. In contrast, inhibition of this pathway during adulthood (late life) extends lifespan. This is consistent with the predictions of the theory of antagonistic pleiotropy, which suggests that genes that are important for fitness early in life limit survival later in life (Williams, 1957). Various groups have now been able to mechanistically link various processes downstream of TORC1 to aging, which provides hope of achieving a more complete understanding of how growth, development and aging are linked with each other (Table 1, Figure 2).

Mediators of TORC1 that modulate lifespan

Stress responses and transcription factors

DR and a number of long-lived mutants enhance resistance to various environmental stresses (Martin et al., 1996; Masoro, 2003). The modulation of stress pathways has been well established to contribute to lifespan extension in multiple species (Martin et al., 1996). As mentioned above, a similar array of stresses also modulates TORC1 activity. This poses the question whether reduced TORC1 activity triggers a stress resistance response. Inhibition of the TOR signaling network and also a number of translation factor genes enhances resistance to various environmental stresses (Hansen et al., 2007; Kaeberlein et al., 2005; Pan et al., 2007; Powers et al., 2006). Evidence from both C. elegans and S. cerevisae suggest that transcription factors involved in mediating stress responses are regulated by TORC1 signaling and mediate its effects on lifespan extension.

In C. elegans, the transcription factor PHA-4 plays an essential role in the embryonic development of the foregut (Mango, 2009). The mammalian orthologs of PHA-4, the Foxa transcription factors Foxa1, Foxa2 and Foxa3, also play important roles during development, and act later in life to regulate glucagon production and glucose homeostasis in response to fasting (Mair and Dillin, 2008). The interaction between PHA-4 and TOR signaling have been uncovered by the finding that inactivation of let-363/tor or rsks-1/s6k can suppress the lethality associated with pha-4 mutants in C. elegans (Sheaffer et al., 2008) Furthermore, lifespan extension by inhibition of S6K was dependent on pha-4 (Sheaffer et al., 2008). PHA-4 has previously been described as a critical regulator of lifespan extension mediated by DR but not other longevity pathways in C. elegans (Panowski et al., 2007). Together, these findings argue for the role of S6K in mediating lifespan extension by DR through PHA-4 dependent mechanisms.

AMPK is the central player that becomes activated upon an increased AMP/ATP ratio, indicating a reduced energy load in the cell. While biochemical evidence places AMPK upstream to TORC1 (Figure 1), their relationship in lifespan regulation is more complex (Figure 2). It has been shown that AMPK acts downstream of S6K and mediates the S6K-dependent effects on body size and lifespan (Selman et al., 2009). In C. elegans, loss of AMPK in a S6K mutant background revert the body size and fecundity defects of the S6K mutant. Though biochemical data demonstrating that AMPK is a direct target of S6K is lacking, the above results place AMPK downstream of S6K in terms of mediating its effects on growth as well as lifespan. However, this apparently counterintuitive result can be reconciled by findings that both in mice and worms, loss of S6K causes increased AMPK activity (Aguilar et al., 2007; Selman et al., 2009). Hence, when DR causes a reduction of TORC1 and S6K, AMPK may become active and lead to sustained TORC1 inhibition. This model suggests that AMPK, TORC1 and S6K1 constitute a feedback signaling loop that resets its activity upon DR to re-direct growth, metabolism and lifespan.

AMPK has also been proposed to be an important mediator of the lifespan extension by DR imposed by dilution of bacteria in the food (Greer et al., 2007). Furthermore, the AMPK agonist, metformin, extends lifespan in at least one genetic strain of mice (Anisimov et al., 2008). Despite the tight biochemical and phenotypic linkage of AMPK and TORC1, it is likely that AMPK also receives inputs independently of TORC1/S6K to influence lifespan. In support of this idea, AMPK has been proposed to partially mediate the lifespan extension observed in the long-lived C. elegans daf-2 mutant (Apfeld et al., 2004). Furthermore, links between AMPK and the ILS pathway have been demonstrated by the finding that human and worm AMPK directly phosphorylates the FOXO transcription factor. DAF-16, the worm ortholog of FOXO is required for the lifespan extension by activation of AMPK (Greer et al., 2007) and also the maximal lifespan extension by DR in some, but not all DR regimes in C. elegans (Greer and Brunet, 2009).

The regulation of the stress-responsive transcription factor HIF-1α is under the control of TORC1 activity at both transcriptional and translational levels (Bernardi et al., 2006; Hui et al., 2006). This idea is supported by findings in cell culture studies showing that rapamycin treated cells fail to adapt to hypoxia (Thomas et al., 2006). Low oxygen concentration results in the stabilization of the transcription factor HIF-1α and the activation of the hypoxic response (Kaelin and Ratcliffe, 2008). HIF-1α helps cells adapt to low oxygen stress by regulating angiogenesis, glycolysis, and cell survival (Semenza, 2000). A recent study suggests that in addition to being responsive to oxygen levels, HIF-1 is also responsive to nutrients and mediates the effects of DR on lifespan extension in C. elegans. Genetic epistasis analysis places HIF-1 downstream of S6K to mediate lifespan extension. A mutation in hif-1 extends lifespan on rich nutrient conditions but does not cause further lifespan extension under DR, whereas the egl-9 mutant, with elevated HIF-1, fails to show maximal lifespan extension under DR. Thus, there is an inverse correlation between HIF-1 activities and lifespan, suggesting that maximal lifespan extension by DR is mediated by HIF-1 in C. elegans (Chen et al., 2009b). This study also found that HIF-1 activity in muscle and specific neurons was critical for mediating its effects on DR (Chen et al., 2009b). Interestingly, an increase in HIF-1 levels in C. elegans has also been implicated in lifespan extension, although by mechanisms distinct from DR (Mehta et al., 2009; Zhang et al., 2009). The reasons for this remain unclear (Kaeberlein and Kapahi, 2009) but may involve the action of HIF-1 in different tissues for its differential effects on lifespan. These findings open a new area of investigation to examine the link between nutrients, oxygen tension, cancer and aging.

In yeast, TORC1 inhibition leads to enhanced resistance to stress and nuclear translocation of Msn2, a stress-induced transcription factor (Powers et al., 2006). Msn2/4 were also found to be translocated to the nucleus and to contribute to lifespan extension upon inhibition of TOR by enhancing the levels of the nicotinamidase gene, PNC1 (Medvedik et al., 2007). The serine/threonine kinase Rim15 positively regulates the stress response transcription factors Gis1 and Msn2/4 and is required for yeast chronological lifespan extension caused by deficiencies in Tor1, Sch9, and by DR. A recent study in S. cerevisiae also found that DR and inhibition of the TOR pathway enhances stress resistance by switching metabolism to enhance glycerol synthesis (Wei et al., 2009). Deletion of the glycerol biosynthesis genes that were up-regulated in long-lived TOR pathway mutants was sufficient to reverse the chronological lifespan extension and enhanced stress resistance, suggesting that glycerol production mediates the enhanced stress resistance and increased chronological lifespan in yeast (Wei et al., 2009). Together, these experiments support the idea that inhibition of TORC1 plays an important role in mediating the switch of cellular resources from growth and reproduction towards somatic maintenance and lifespan extension.

Autophagy

Autophagy is defined as a highly regulated cellular starvation response to maintain essential nutrient levels and viability. During macroautophagy, various cytoplasmic components, including organelles, are enclosed within a double-membrane structure (the autophagosome) and delivered to the vacuole (in S. cerevisiae) or lysosome (in other eukaryotic cells) for degradation and recycling of the degradation products (Cecconi and Levine, 2008; Diaz-Troya et al., 2008). The role of autophagy in modulating lifespan was first identified when the extended lifespan of the C. elegans mutant in daf-2, which encodes an insulin like receptor, was significantly abrogated by inhibition of the autophagy gene bec-1 (Melendez et al., 2003). As inhibition of autophagy does not compromise the lifespan of control animals in both worms and flies (Hansen et al., 2008; Melendez et al., 2003; Ren et al., 2009), this observation supports the idea that enhanced autophagy may extend lifespan. Inhibition of TORC1 enhances autophagy and provides an attractive mechanism to explain the effects of reduced TORC1 activity on lifespan. In fact, autophagy is also required for the lifespan extension mediated by DR or inhibition of TORC1 (Hansen et al., 2008; Toth et al., 2008). Additionally, lifespan extension by the eat-2 mutation can be suppressed by inhibition of autophagy genes using RNAi (Hansen et al., 2008; Jia and Levine, 2007). Increased autophagy has been observed under DR and requires the FOXA transcription factor PHA-4 (Hansen et al., 2008), which is also a critical regulator of lifespan extension mediated by DR (Panowski et al., 2007) and in S6K mutants (Sheaffer et al., 2008). Together these experiments implicate an important role for autophagy in lifespan extension by DR. Future experiments examining the role of autophagy in specific tissues will be especially useful to our understanding its effects on lifespan.

Endoplasmic Reticulum (ER) stress

ER stress is caused by a mismatch between the load of unfolded/misfolded proteins within the ER and the capacity of the cellular machinery to cope with it (Ron and Walter, 2007). An increase in ER stress and activation of the unfolded protein response (UPR) in mammalian cells has been observed in response to excess nutrients (Ozcan et al., 2004) or enhanced TORC1 signaling due to loss of TSC1 or TSC2 (Ozcan et al., 2008). Genes that help cope with ER stress have been shown to mediate lifespan extension in both S. cerevisiae (Steffen et al., 2008) and C. elegans (Chen et al., 2009b). One possibility is that GCN4, which mediates the lifespan extension effects of DR, enhances survival by modulating ER signaling (Steffen et al., 2008). This is supported by the findings that GCN4 has been shown to regulate a number of genes required for UPR in S. cerevisiae (Patil et al., 2004). Consistent with a role for the ER signaling pathway in C. elegans aging, ire-1 was found to be required for lifespan determination by DR and by loss of hif-1 function (Chen et al., 2009b). IRE-1 is an ER transmembrane protein with kinase and RNAse activities, which senses misfolded proteins in the ER lumen and responds by splicing the xbp-1 mRNA. This allows the translation of functional XBP-1 protein which regulates target genes required for increased ER stress resistance (Ron and Walter, 2007). These studies open a rich area of investigation to examine the mechanisms by which ER stress signaling, which has been linked with obesity and diabetes, mediates DR dependent lifespan extension.

Metabolism

DR has significant effects on metabolism, which has been suggested to modulate the rate of aging (Masoro, 2003). Two studies have shown that increased mitochondrial function by either inhibition of TORC1 or by DR contributes to the lifespan extension in S. cerevisiae and D. melanogaster. This is a surprising finding given that it is widely believed that enhanced mitochondrial function would result in increased oxidative damage by ROS (reactive oxygen species). The first study proposes that deletion of the TOR1 gene extends chronological lifespan in S. cerevisiae by increasing mitochondrial respiration via enhanced translation of mtDNA-encoded oxidative phosphorylation complexes (Bonawitz et al., 2007). The increased chronological lifespan upon deletion of TOR1 was reversed by inhibition of ETC function. The second study showed that in D. melanogaster, DR causes increased translation of nuclear-encoded mitochondrial genes, encoding for ETC and ribosomal proteins, thereby enhancing mitochondrial density and function (Zid et al., 2009). The role of mitochondrial function in mediating lifespan extension in D. melanogaster was confirmed by the observation that inhibition of complex I throughout the whole body abrogated the lifespan extension by DR (Zid et al., 2009).

These observations suggest that the translational regulation of mitochondrial function and its protective effects during DR may be conserved in different species. Surprisingly, and in contrast to these findings, it has been observed that in C. elegans, inhibition of components of the ETC also lead to lifespan extension (Aguilaniu et al., 2005). These observations are counterintuitive to the proposed idea that a deficiency of ETC function with age, observed in multiple species, may be responsible for organismal aging (McCarroll et al., 2004). One possible explanation reconciling these contradictory findings is that lifespan extension by reduction of ETC function is tissue specific. In support of this idea it has recently been shown that inhibition of ETC in neurons can extend lifespan even in D. melanogaster (Copeland et al., 2009). Hence, it is conceivable that age-related decline in mitochondrial function may contribute to aging by action in non-neuronal tissues.

An outstanding question is how increased reliance on mitochondrial respiration extends lifespan. The activity level of TORC1 might regulate the switch between glycolysis and mitochondrial respiration for the generation of ATP. Highly active TORC1 promotes high levels of HIF-1, shifting the cell towards glycolysis. In contrast, TORC1 inhibition favors mitochondrial ATP generation. The subsequent increase in mitochondrial oxygen consumption might actually limit intracellular oxygen and ROS-mediated damage associated with aging (Bonawitz et al., 2007). Alternatively, the enhanced translation of mitochondrial ETC genes serves as a protective mechanism not only by increasing mitochondrial efficiency but also by maintaining the function of the ETC and, hence, ATP production, which is known to decline with age (McCarroll et al., 2004). The shift of cancer cells away from mitochondrial respiration towards glycolysis for ATP generation even in the presence of oxygen has been termed the Warburg effect (Warburg, 1956). A causal role for mitochondrial respiration in tumorigenesis is supported by findings that succinate dehydrogenase and fumarate hydratase are tumor suppressor genes (King et al., 2006). However, future work in this area is required to identify the mechanisms by which the mitochondrial function exerts protective effects to slow aging and cancer progression.

Summary and future outlook

We have summarized the ample evidence for the role of nutrient and stress sensing by the TOR signaling network in mediating responses to DR. Strong evidence supports a regulatory role for reduced TOR signaling network activity to extend lifespan, as this is observed in all model organisms tested so far (Figure 2). This provides a strong framework and excellent tools for exploring the link between nutrient limitation and lifespan extension. A conserved role for many components of this network including TOR, S6K and AMPK is emerging. This body of work provides an array of excellent putative drug targets for extending lifespan and slowing age-related diseases.

However, future work in this area examining the role of different types of nutrients in various species to modulate lifespan is needed to better assess the role of TOR in lifespan extension by dietary restriction. Furthermore, it remains to be seen which downstream effectors of TOR are key drivers of the longevity phenotype and which ones elicit only minor effects. The role of various tissues and their communication to determine organismal lifespan also remain poorly understood. Moreover, a number of pathways that modulate aging are being discovered, which display effects on lifespan seemingly independent of TORC1. The central challenge of aging research remains to flesh out a unified picture of mechanisms determining aging. Further analyses of TOR and other conserved pathways will shed light on the link between diet and various age-related diseases such as cancer, neurodegeneration and diabetes in humans.